Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Higher Serum Testosterone Levels Associated with Favorable Prognosis in Enzalutamide- and Abiraterone-Treated Castration-Resistant Prostate Cancer.

Sakamoto S, Maimaiti M, Xu M, Kamada S, Yamada Y, Kitoh H, Matsumoto H, Takeuchi N, Higuchi K, Uchida HA, Komiya A, Nagata M, Nakatsu H, Matsuyama H, Akakura K, Ichikawa T.

J Clin Med. 2019 Apr 11;8(4). pii: E489. doi: 10.3390/jcm8040489.

2.

Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma.

Yamada Y, Arai T, Kato M, Kojima S, Sakamoto S, Komiya A, Naya Y, Ichikawa T, Seki N.

Am J Clin Exp Urol. 2019 Feb 18;7(1):11-30. eCollection 2019.

3.

Oncological and renal outcomes of segmental ureterectomy vs. radical nephroureterectomy for upper tract urothelial carcinoma.

Kato T, Nakayama R, Haba T, Kawaguchi M, Komiya A, Koike H.

Oncol Lett. 2018 Nov;16(5):6861-6867. doi: 10.3892/ol.2018.9463. Epub 2018 Sep 19.

4.

Vasovasostomy and vasoepididymostomy: Review of the procedures, outcomes, and predictors of patency and pregnancy over the last decade.

Namekawa T, Imamoto T, Kato M, Komiya A, Ichikawa T.

Reprod Med Biol. 2018 May 22;17(4):343-355. doi: 10.1002/rmb2.12207. eCollection 2018 Oct. Review.

5.

PSA response following the 'steroid switch' in patients with castration-resistant prostate cancer treated with abiraterone: A case report.

Kato T, Kojima S, Fujimoto A, Otsuka K, Suyama T, Hou K, Araki K, Masuda H, Yamazaki K, Komiya A, Naya Y.

Oncol Lett. 2018 Oct;16(4):5383-5388. doi: 10.3892/ol.2018.9321. Epub 2018 Aug 17.

6.

Treatment strategy for metastatic prostate cancer with extremely high PSA level: reconsidering the value of vintage therapy.

Yamada Y, Sakamoto S, Amiya Y, Sasaki M, Shima T, Komiya A, Suzuki N, Akakura K, Ichikawa T, Nakatsu H.

Asian J Androl. 2018 Sep-Oct;20(5):432-437. doi: 10.4103/aja.aja_24_18.

7.

Contralateral adrenal width predicts the duration of prolonged post-surgical steroid replacement for subclinical Cushing syndrome.

Sugiura M, Imamura Y, Kawamura K, Yamamoto S, Sazuka T, Nakamura K, Sakamoto S, Nagano H, Koide H, Tanaka T, Imamoto T, Komiya A, Ichikawa T.

Int J Urol. 2018 Jun;25(6):583-588. doi: 10.1111/iju.13566. Epub 2018 Apr 12.

PMID:
29651813
8.

Biparametric Prostate Imaging Reporting and Data System version2 and International Society of Urological Pathology Grade Predict Biochemical Recurrence after Radical Prostatectomy.

Takeuchi N, Sakamoto S, Nishiyama A, Horikoshi T, Yamada Y, Iizuka J, Maimaiti M, Imamura Y, Kawamura K, Imamoto T, Komiya A, Ikehara Y, Akakura K, Ichikawa T.

Clin Genitourin Cancer. 2018 Aug;16(4):e817-e829. doi: 10.1016/j.clgc.2018.02.011. Epub 2018 Feb 24.

PMID:
29576444
9.

Abiraterone acetate withdrawal syndrome: Speculations on the underlying mechanisms.

Kato T, Komiya A, Yuasa J, Kaga K, Kaga M, Kojima S, Naya Y, Isaka S.

Oncol Lett. 2018 Feb;15(2):2669-2672. doi: 10.3892/ol.2017.7628. Epub 2017 Dec 14.

10.

Duration of androgen deprivation therapy and nadir of testosterone at 20 ng/dL predict testosterone recovery to supracastrate level in prostate cancer patients who received external beam radiotherapy.

Takei A, Sakamoto S, Wakai K, Tamura T, Imamura Y, Xu M, Maimaiti M, Kawamura K, Imamoto T, Komiya A, Akakura K, Ichikawa T.

Int J Urol. 2018 Apr;25(4):352-358. doi: 10.1111/iju.13521. Epub 2018 Jan 11.

11.

Significant prognostic difference between Grade Group 4 and 5 in the 2014 International Society of Urological Pathology Grading System for High Grade Prostate Cancer with Bone Metastasis.

Yamada Y, Sakamoto S, Shimazaki J, Sugiura M, Amiya Y, Sasaki M, Shima T, Komiya A, Suzuki N, Akakura K, Ichikawa T, Nakatsu H.

Prostate Int. 2017 Dec;5(4):143-148. doi: 10.1016/j.prnil.2017.03.001. Epub 2017 Mar 16.

12.

Testosterone Reduction of ≥ 480 ng/dL Predicts Favorable Prognosis of Japanese Men With Advanced Prostate Cancer Treated With Androgen-Deprivation Therapy.

Yamamoto S, Sakamoto S, Minhui X, Tamura T, Otsuka K, Sato K, Maimaiti M, Kamada S, Takei A, Fuse M, Kawamura K, Imamoto T, Komiya A, Akakura K, Ichikawa T.

Clin Genitourin Cancer. 2017 Dec;15(6):e1107-e1115. doi: 10.1016/j.clgc.2017.07.023. Epub 2017 Aug 3.

PMID:
28882738
13.

Nationwide, Multicenter, Retrospective Study on High-Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer.

Yoshioka Y, Kotsuma T, Komiya A, Kariya S, Konishi K, Nonomura N, Ogawa K, Tanaka E, Nishimura K, Fujiuchi Y, Kitamura H, Yamagami T, Yamasaki I, Nishimura K, Teshima T, Nakamura K, Itami J.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):952-961. doi: 10.1016/j.ijrobp.2016.12.013. Epub 2016 Dec 18.

PMID:
28333018
14.

[KOUJIN POWDER (RED GINSENG POWDER) WITH NINJIN-YOUEITO FOR FATIGUE DUE TO TARGETED THERAPY FOR ADVANCED RENAL CELL CARCINOMA: A RETROSPECTIVE COHORT STUDY].

Nakamura K, Goto Y, Sazuka T, Imamura Y, Komiya A, Ichikawa T.

Nihon Hinyokika Gakkai Zasshi. 2017;108(4):194-199. doi: 10.5980/jpnjurol.108.194. Japanese.

15.

Trousseau's syndrome caused by bladder cancer producing granulocyte colony-stimulating factor and parathyroid hormone-related protein: A case report.

Kato T, Yasuda K, Iida H, Watanabe A, Fujiuchi Y, Miwa S, Imura J, Komiya A.

Oncol Lett. 2016 Nov;12(5):4214-4218. Epub 2016 Sep 20.

16.
17.

[Antiandrogen withdrawal syndrome].

Komiya A, Kato T, Yasuda K, Watanabe A, Okumura A.

Nihon Rinsho. 2016 May 20;74 Suppl 3:584-8. Japanese. No abstract available.

PMID:
27344798
18.

Wild-type ATTR amyloidosis of the ureter in a 56-year-old woman with rheumatoid arthritis and Sjögren's syndrome.

Shinoda K, Taki H, Obayashi K, Ando Y, Watanabe A, Komiya A, Fuse H, Tsuneyama K, Tobe K.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8624-7. eCollection 2015.

19.

Retraction-Related Acute Liver Failure after Urological Laparoscopic Surgery.

Nozaki T, Kato T, Komiya A, Fuse H.

Curr Urol. 2014 Oct;7(4):199-203. doi: 10.1159/000365676. Epub 2014 Aug 20.

20.

Analysis of Japanese Patients Treated with or without Long-Term Epirubicin Plus Ara-C Intravesical Instillation Therapy for Low-Grade Superficial Bladder Cancer.

Kato T, Nomura K, Kondo F, Wakisaka M, Komiya A.

ScientificWorldJournal. 2015;2015:325305. doi: 10.1155/2015/325305. Epub 2015 May 21.

Supplemental Content

Loading ...
Support Center